Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Meulenberg, H. Vijverberg (2000)
Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds.Toxicology and applied pharmacology, 165 3
G. Eisenbrand, B. Pool-Zobel, V. Baker, M. Balls, B. Blaauboer, Alan Boobis, Angelo Carere, S. Kevekordes, J. Lhuguenot, Raymond Pieters, J. Kleiner (2002)
Methods of in vitro toxicology.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 40 2-3
E. Nuwaysir, M. Bittner, J. Trent, J. Barrett, C. Afshari (1999)
Microarrays and toxicology: The advent of toxicogenomicsMolecular Carcinogenesis, 24
Patrick Poulin, Kannan Krishnan (1996)
A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals.Toxicology and applied pharmacology, 136 1
H. Harries, S. Fletcher, C. Duggan, V. Baker (2001)
The use of genomics technology to investigate gene expression changes in cultured human liver cells.Toxicology in vitro : an international journal published in association with BIBRA, 15 4-5
P. Artursson, Katrin Palm, K. Luthman (2001)
Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1Advanced Drug Delivery Reviews, 46
P. Artursson, J. Karlsson (1991)
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.Biochemical and biophysical research communications, 175 3
Cyrille Krul, A. Luiten-Schuite, R. Baan, H. Verhagen, G. Mohn, V.J Feron, R. Havenaar (2000)
Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 38 9
W. Russell, R. Burch (1960)
The Principles of Humane Experimental TechniqueMedical Journal of Australia, 1
E. Ferrec, C. Chesné, P. Artusson, David Brayden, G. Fabre, Pierre Gires, F. Guillou, M. Rousset, W. Rubas, M. Scarino (2001)
In Vitro Models of the Intestinal BarrierAlternatives to Laboratory Animals, 29
D. Basketter, A. Dooms‐goossens, A. Karlberg, J. Lepoittevin (1995)
The chemistry of contact allergy: why is a molecule allergenic?Contact Dermatitis, 32
H. Clewell (1993)
Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing.Toxicology letters, 68 1-2
(2000)
An integrated approach to the prediction of systemic toxicity using biokinetic models and biological in vitro test methods
B. Blaauboer, M. Barratt, J. Houston (1999)
The Integrated Use of Alternative Methods in Toxicological Risk EvaluationAlternatives to Laboratory Animals, 27
M. Cronin, J. Dearden, Ravi Gupta, G. Moss (1998)
An Investigation of the Mechanism of Flux Across Polydimethylsiloxane Membranes by use of Quantitative Structure‐Permeability RelationshipsJournal of Pharmacy and Pharmacology, 50
P. Poulin, K. Krishnan (1995)
A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicalsHuman & Experimental Toxicology, 14
M. Andersen, H. Clewell, M. Gargas, F. Smith, R. Reitz (1987)
Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.Toxicology and applied pharmacology, 87 2
M. Barratt (2004)
Prediction of toxicity from chemical structureCell Biology and Toxicology, 16
R. Reitz, A. Mendrala, C. Park, M. Andersen, F. Guengerich (1988)
Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment.Toxicology letters, 43 1-3
B. Blaauboer (2002)
The applicability of in vitro-derived data in hazard identification and characterisation of chemicals.Environmental toxicology and pharmacology, 11 3-4
G. Moss, J. Dearden, Hiren Patel, M. Cronin (2002)
Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption.Toxicology in vitro : an international journal published in association with BIBRA, 16 3
B. Blaauboer, Michael Balls, M. Barratt, Silvia Casati, S. Coecke, Mostafa Mohamed, Jack Moore, D. Rall, Kirk Smith, R. Tennant, B. Schwetz, William Stokes, Maged Younes (1998)
13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues.Environmental Health Perspectives, 106
V. Fiserova-Bergerova, M. Díaz (1986)
Determination and prediction of tissue-gas partition coefficientsInternational Archives of Occupational and Environmental Health, 58
Ronald Brown, M. Delp, S. Lindstedt, L. Rhomberg, R. Beliles (1997)
Physiological Parameter Values for Physiologically Based Pharmacokinetic ModelsToxicology and Industrial Health, 13
(1990)
Toxicity testing: strategies and conduct
J. Ramsey, M. Andersen (1984)
A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.Toxicology and applied pharmacology, 73 1
J. DeJongh, H. Verhaar, J. Hermens (1997)
A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humansArchives of Toxicology, 72
B. Blaauboer, H. Wortelboer, W. Mennes (1990)
The Use of Liver Cell Cultures Derived from Different Mammalian Species in In Vitro Toxicological Studies: Implementation in Extrapolation Models?Alternatives to Laboratory Animals, 18
C. Atterwill, H. Johnston, S. Thomas (1992)
Models for the in vitro assessment of neurotoxicity in the nervous system in relation to xenobiotic and neurotrophic factor-mediated events.Neurotoxicology, 13 1
M. Balls, A. Bogni, S. Bremer, S. Casati, S. Coecke, C. Eskes, P. Prieto, E. Sabbioni, Andrew Worth, V. Zuang, M. Barratt, B. Blaauboer, P. Botham, R. Combes, J. Doehmer, J. Fentem, M. Liebsch, H. Spielmann (2002)
Alternative (non-animal) methods for chemicals testing: Current status and future prospects - OverviewAtla-alternatives To Laboratory Animals, 30
R. Kanter, D. Jager, A. Draaisma, JU Jurva, P. Olinga, D. Meijer, G. Groothuis (2002)
Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slicesXenobiotica, 32
P. Artursson, R. Borchardt (1997)
Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and BeyondPharmaceutical Research, 14
H. Clewell, M. Andersen (1986)
A Multiple Dose-Route Physiological Pharmacokinetic Model for Volatile Chemicals Using ACSL/PC,
R. Obach, J. Baxter, T. Liston, B. Silber, B. Jones, Fiona Macintyre, D. Rance, P. Wastall (1997)
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.The Journal of pharmacology and experimental therapeutics, 283 1
B. Ekwall (1983)
SCREENING OF TOXIC COMPOUNDS IN MAMMALIAN CELL CULTURESAnnals of the New York Academy of Sciences, 407
J. Houston, D. Carlile (1997)
Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices.Drug metabolism reviews, 29 4
A. Forsby, F. Pilli, V. Bianchi, E. Walum (1995)
Determination of Critical Cellular Neurotoxic Concentrations in Human Neuroblastoma (SH-SY5Y) Cell CulturesAlternatives to Laboratory Animals, 23
J. Frazier (1992)
In vitro toxicity testing : applications to safety evaluation
M. Barratt, M. Dixit, P. Jones (1996)
The use of in vitro cytotoxicity measurements in QSAR methods for the prediction of the skin corrosivity potential of acids.Toxicology in vitro : an international journal published in association with BIBRA, 10 3
O. Flint (1990)
In Vitro Toxicity Testing: Purpose, Validation and StrategyAlternatives to Laboratory Animals, 18
Data derived from in vitro toxicity studies are not directly applicable in an assessment of the toxicity of compounds in intact organisms. The major limitation is the lack of knowledge of biokinetic behaviour in vivo. Since the toxicity of a compound will be determined by the critical concentration (or other dose metric) of the critical compound (or a metabolite thereof) at the critical site of toxic action, biokinetic behaviour must be taken into account. Possibilities of biokinetic modelling on the basis of in vitro and other non-animal data are discussed, and the application of the results in hazard and risk-assessment schedules is considered.
Alternatives to Laboratory Animals – SAGE
Published: Dec 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.